|
1
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al: Global surveillance of cancer survival 1995–2009: Analysis
of individual data for 25,676,887 patients from 279
population-based registries in 67 countries (CONCORD-2). Lancet.
385:977–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Riaz SP, Lüchtenborg M, Coupland VH,
Spicer J, Peake MD and Møller H: Trends in incidence of small cell
lung cancer and all lung cancer. Lung Cancer. 75:280–284. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Toschi L, Cappuzzo F and Jänne PA:
Evolution and future perspectives in the treatment of locally
advanced non-small cell lung cancer. Ann Oncol. 18 (Suppl
9):ix150–ix155. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhong J, Huang R, Su Z, Zhang M, Xu M,
Gong J, Chen N, Zeng H, Chen X and Zhou Q: Downregulation of
miR-199a-5p promotes prostate adeno-carcinoma progression through
loss of its inhibition of HIF-1α. Oncotarget. 8:83523–83538. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Turashvili G, Lightbody ED, Tyryshkin K,
SenGupta SK, Elliott BE, Madarnas Y, Ghaffari A, Day A and Nicol
CJB: Novel prognostic and predictive microRNA targets for
triple-negative breast cancer. FASEB J. May 29–2018.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ghosh A, Dasgupta D, Ghosh A, Roychoudhury
S, Kumar D, Gorain M, Butti R, Datta S, Agarwal S, Gupta S, et al:
MiRNA199a-3p suppresses tumor growth, migration, invasion and
angiogenesis in hepatocellular carcinoma by targeting VEGFA,
VEGFR1, VEGFR2, HGF and MMP2. Cell Death Dis. 8:e27062017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gadducci A, Sergiampietri C, Lanfredini N
and Guiggi I: Micro-RNAs and ovarian cancer: The state of art and
perspectives of clinical research. Gynecol Endocrinol. 30:266–271.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye H, Pang L, Wu Q, Zhu Y, Guo C, Deng Y
and Zheng X: A critical role of mir-199a in the cell biological
behaviors of colorectal cancer. Diagn Pathol. 10:652015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ahmadi A, Khansarinejad B, Hosseinkhani S,
Ghanei M and Mowla SJ: miR-199a-5p and miR-495 target GRP78 within
UPR pathway of lung cancer. Gene. 620:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu Y, Liu J, Jiang B, Chen J, Fu Z, Bai F,
Jiang J and Tang Z: MiR-199a-5p loss up-regulated DDR1 aggravated
colorectal cancer by activating epithelial-to-mesenchymal
transition related signaling. Dig Dis Sci. 59:2163–2172. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo W, Qiu Z, Wang Z, Wang Q, Tan N, Chen
T, Chen Z, Huang S, Gu J, Li J, et al: miR-199a-5p is negatively
associated with malignancies and regulates glycolysis and lactate
production by targeting hexokinase 2 in liver cancer. Hepatology.
62:1132–1144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li W, Wang H, Zhang J, Zhai L, Chen W and
Zhao C: miR-199a-5p regulates β1 integrin through Ets-1 to suppress
invasion in breast cancer. Cancer Sci. 107:916–923. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Wang D, Li X, Shao Y, He Y, Yu H and
Ma Z: MiR-199a-5p suppresses non-small cell lung cancer via
targeting MAP3K11. J Cancer. 10:2472–2479. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Merrill RA and Strack S: A-kinase
anchoring protein 1: Emerging roles in regulating mitochondrial
form and function in health and disease. Cells. 9:2982020.
View Article : Google Scholar
|
|
15
|
Yu J, Zhang Y, Zhou D, Wu J and Luo R:
Higher expression of A-kinase anchoring-protein 1 predicts poor
prognosis in human hepatocellular carcinoma. Oncol Lett.
16:131–136. 2018.PubMed/NCBI
|
|
16
|
Li B, Wang W, Li Z, Chen Z, Zhi X, Xu J,
Li Q, Wang L, Huang X, Wang L, et al: MicroRNA-148a-3p enhances
cisplatin cytotoxicity in gastric cancer through mitochondrial
fission induction and cyto-protective autophagy suppression. Cancer
Lett. 410:212–227. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rinaldi L, Sepe M, Delle Donne R, Conte K,
Arcella A, Borzacchiello D, Amente S, De Vita F, Porpora M, Garbi
C, et al: Mitochondrial AKAP1 supports mTOR pathway and tumor
growth. Cell Death Dis. 8:e28422017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rami-Porta R, Bolejack V, Crowley J, Ball
D, Kim J, Lyons G, Rice T, Suzuki K, Thomas CF Jr, Travis WD, et
al: The IASLC Lung cancer staging project: Proposals for the
revisions of the T descriptors in the forthcoming eighth edition of
the TNM classification for lung cancer. J Thorac Oncol.
10:990–1003. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Travis WD: The 2015 WHO classification of
lung tumors. Pathologe. 35 (Suppl 2):1882014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen K, Chen H, Yang F, Sui X, Li X and
Wang J: Validation of the eighth edition of the TNM staging system
for lung cancer in 2043 surgically treated patients with
non-small-cell lung cancer. Clin Lung Cancer. 18:e457–e466. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng Y, Zhao F, Hui L, Li X, Zhang D, Lin
W, Chen Z and Ning Y: Suppressing miR-199a-3p by promoter
methylation contributes to tumor aggressiveness and cisplatin
resistance of ovarian cancer through promoting DDR1 expression. J
Ovarian Res. 10:502017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iqbal MA, Arora S, Prakasam G, Calin GA
and Syed MA: MicroRNA in lung cancer: Role, mechanisms, pathways
and therapeutic relevance. Mol Aspects Med. 70:3–20. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karube Y, Tanaka H, Osada H, Tomida S,
Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S,
Mitsudomi T and Takahashi T: Reduced expression of Dicer associated
with poor prognosis in lung cancer patients. Cancer Sci.
96:111–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kalscheuer S, Zhang X, Zeng Y and
Upadhyaya P: Differential expression of microRNAs in early-stage
neoplastic transformation in the lungs of F344 rats chronically
treated with the tobacco carcinogen
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis.
29:2394–2399. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mascaux C, Laes JF, Anthoine G, Haller A,
Ninane V, Burny A and Sculier JP: Evolution of microRNA expression
during human bronchial squamous carcinogenesis. Eur Respir J.
33:352–359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang QZ, Xu W, Habib N and Xu R: Potential
uses of microRNA in lung cancer diagnosis, prognosis, and therapy.
Curr Cancer Drug Targets. 9:572–594. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sanfiorenzo C, Ilie MI, Belaid A, Barlési
F, Mouroux J, Marquette CH, Brest P and Hofman P: Two panels of
plasma microRNAs as non-invasive biomarkers for prediction of
recurrence in resectable NSCLC. PLoS One. 8:e545962013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin Y, Wang H, Zhu Y, Feng H, Wang G and
Wang S: miR-199a-5p is involved in doxorubicin resistance of
non-small cell lung cancer (NSCLC) cells. Eur J Pharmacol.
878:1731052020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L,
Liu J and Huang G: LINC01123, a c-Myc-activated long non-coding
RNA, promotes proliferation and aerobic glycolysis of non-small
cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol.
12:912019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang C, Han C, Zhang Y and Liu F: LncRNA
PVT1 regulate expression of HIF1α via functioning as ceRNA for
miR-199a-5p in non-small cell lung cancer under hypoxia. Mol Med
Rep. 17:1105–1110. 2018.PubMed/NCBI
|
|
34
|
Suzuki H, Maruyama R, Yamamoto E and Kai
M: DNA methylation and microRNA dysregulation in cancer. Mol Oncol.
6:567–578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Weber B, Stresemann C, Brueckner B and
Lyko F: Methylation of human microRNA genes in normal and
neoplastic cells. Cell Cycle. 6:1001–1005. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang J, Fu J, Pan Y, Zhang X and Shen L:
Silencing of miR-1247 by DNA methylation promoted non-small-cell
lung cancer cell invasion and migration by effects of STMN1. Onco
Targets Ther. 9:7297–7307. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu C, Lv D, Li M, Zhang X, Sun G, Bai Y
and Chang D: Hypermethylation of miRNA-589 promoter leads to
upregulation of HDAC5 which promotes malignancy in non-small cell
lung cancer. Int J Oncol. 50:2079–2090. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xia W, Chen Q, Wang J, Mao Q, Dong G, Shi
R, Zheng Y, Xu L and Jiang F: DNA methylation mediated silencing of
microRNA-145 is a potential prognostic marker in patients with lung
adenocarcinoma. Sci Rep. 5:169012015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT
and Wang YC: Alteration of DNA methyltransferases contributes to
5′CpG methylation and poor prognosis in lung cancer. Lung Cancer.
55:205–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Martinez-Outschoorn UE, Pestell RG, Howell
A, Tykocinski ML, Nagajyothi F, Machado FS, Tanowitz HB, Sotgia F
and Lisanti MP: Energy transfer in ‘parasitic’ cancer metabolism:
Mitochondria are the powerhouse and Achilles' heel of tumor cells.
Cell Cycle. 10:4208–4216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sotgia F, Martinez-Outschoorn UE and
Lisanti MP: Cancer metabolism: New validated targets for drug
discovery. Oncotarget. 4:1309–1316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Livigni A, Scorziello A, Agnese S,
Adornetto A, Carlucci A, Garbi C, Castaldo I, Annunziato L,
Avvedimento EV and Feliciello A: Mitochondrial AKAP121 links cAMP
and src signaling to oxidative metabolism. Mol Biol Cell.
17:263–271. 2006. View Article : Google Scholar : PubMed/NCBI
|
